Skip to main content
OpenTrials

Clinical trial condition

Diphtheria

Explore clinical trials studying Diphtheria. Study availability and eligibility vary by location and protocol.

202 public trials 3 recruiting studies
Refine in advanced search Browse all conditions

Diphtheria trial results

Completed

Study to Determine the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals; Infanrix Hexa at 2, 4 and 6 Months of Age in Healthy Infants

NCT02096263

Conditions
Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +32 more
Locations
  • GSK Investigational Site Tucson, Arizona, United States
  • GSK Investigational Site Fayetteville, Arkansas, United States
  • GSK Investigational Site Anaheim, California, United States
  • GSK Investigational Site Daly City, California, United States
View all 43 locations
View Trial Details
Completed

A Study to Assess the Immunogenicity and Safety of GSK Biologicals' Infanrix-IPV/Hib Vaccine Administered as a Three-dose Vaccination Course at 3, 4.5 and 6 Months of Age and a Booster Dose at 18 Months of Age in Healthy Infants in Russia

NCT02858440

Conditions
Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +25 more
Locations
  • GSK Investigational Site Barnaul, Russia
  • GSK Investigational Site Murmansk, Russia
  • GSK Investigational Site Saint Petersburg, Russia
  • GSK Investigational Site Tomsk, Russia
View Trial Details
Completed

Immunogenicity and Safety Study of Infanrix Hexa in Healthy Infants Born to Mothers Vaccinated With Boostrix™ During Pregnancy or Immediately Post-delivery

NCT02422264

Conditions
Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +20 more
Locations
  • GSK Investigational Site Carlton, Victoria, Australia
  • GSK Investigational Site Calgary, Alberta, Canada
  • GSK Investigational Site Halifax, Nova Scotia, Canada
  • GSK Investigational Site Montreal, Quebec, Canada
View all 30 locations
View Trial Details
Completed

Immunogenicity, Safety of GSKs Tdap Vaccine Boostrix When Coadministered With GSKs Influenza Vaccine Fluarix in Adults

NCT00385255

Conditions
Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +13 more
Locations
  • GSK Investigational Site Huntsville, Alabama, United States
  • GSK Investigational Site Chandler, Arizona, United States
  • GSK Investigational Site Mesa, Arizona, United States
  • GSK Investigational Site Phoenix, Arizona, United States
View Trial Details

Related conditions